Related Experiment Videos
Asymptomatic pancreatitis associated with clozapine
N Bergemann1, C Ehrig, K Diebold
1Department of Psychiatry, University of Heidelberg, Germany. niels_bergemann@ukl.uni-heidelberg.de
Pharmacopsychiatry
|May 20, 1999
Summary
Clozapine treatment can cause rare pancreatitis. This case study found asymptomatic pancreatitis during clozapine dose increases, suggesting it may be underdiagnosed. Monitoring pancreatic enzymes is recommended.
Area of Science:
- Psychiatry
- Gastroenterology
- Pharmacology
Background:
- Clozapine is an atypical antipsychotic used for treatment-resistant schizophrenia.
- Known adverse effects include granulocytopenia, sedation, and hypersalivation.
- Acute pancreatitis is a very rare, reported complication of clozapine therapy.
Observation:
- A 38-year-old male with schizophrenia experienced asymptomatic pancreatitis during clozapine dose escalation.
- Elevated serum amylase and lipase levels normalized despite continued therapeutic clozapine doses.
- Ultrasound revealed only minor pancreatic thickening; no patient-reported symptoms occurred.
Findings:
- Subclinical pancreatitis may occur more frequently than previously recognized during clozapine titration.
- Pancreatic enzyme levels fluctuated with clozapine dosage adjustments.
- The asymptomatic nature of the pancreatitis highlights potential underdiagnosis.
Implications:
- Monitoring serum amylase during slow clozapine dose increases is advisable.
- Consider subclinical pancreatitis in patients on clozapine with unexplained leukocytosis or eosinophilia.
- This finding may influence future monitoring protocols for clozapine-induced pancreatitis.